Dr. Barry Dworkin

Newly discovered inflammation pathway may lead to new treatments for Alzheimer Disease

Health Headlines Commentary for January 11, 2016

Source:

Blocking brain inflammation ‘halts Alzheimer’s disease’

Reference:

Pharmacological targeting of CSF1R inhibits microglial proliferation and prevents the progression of Alzheimer’s-like pathology

Related posts:

  1. Alzheimer drug trial failure offers much to learn and should not be seen as a dead end
  2. THC activity on the developing adolescent brain may potentiate risk of schizophrenia in susceptible individuals
  3. Lack of evidence that painkillers like naproxen are helpful for treating Alzheimer’s disease
  4. New hypothesis proposes that Alzheimer’s is principally a disorder of the immune system within the brain. This, given alleged fabricated data in paper published in Nature in 2006, linking beta-amyloid as the causative agent.